These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8117405)

  • 41. [Ototoxicity of erythromycin].
    van Marion WF; van der Meer JW; Kalff MW; Schicht SM; Baarsma EA
    Ned Tijdschr Geneeskd; 1979 Dec; 123(48):2066-8. PubMed ID: 514397
    [No Abstract]   [Full Text] [Related]  

  • 42. Ototoxicity of erythromycin in peritoneal dialysis patients.
    Taylor R; Schofield IS; Ramos JM; Bint AJ; Ward MK
    Lancet; 1981 Oct; 2(8252):935-6. PubMed ID: 6117714
    [No Abstract]   [Full Text] [Related]  

  • 43. Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients.
    Schmidt LE; Rasmussen A; Kirkegaard P; Dalhoff K
    Transplantation; 2003 Jul; 76(2):358-63. PubMed ID: 12883193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
    Wiesner B; Wilen-Rosenqvist G; Lehtonen L
    Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical trial of erythromycin stearate suspension.
    McLeay AC; Beveridge J
    Med J Aust; 1971 Apr; 1(15):793-6. PubMed ID: 4929585
    [No Abstract]   [Full Text] [Related]  

  • 46. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate.
    Keeffe EB; Reis TC; Berland JE
    Dig Dis Sci; 1982 Aug; 27(8):701-4. PubMed ID: 6980110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Tolerance and effectiveness of oral erythromycin ethyl succinate, intravenous Lactobionate and erythromycin base in infants and small children].
    Krepler P; Steinwenter A
    Arch Kinderheilkd; 1970 Jan; 180(2):129-50. PubMed ID: 5443953
    [No Abstract]   [Full Text] [Related]  

  • 48. [The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--first report: comparison with amoxicillin].
    Sawaki M; Mikami R; Mikasa K; Kunimatsu M; Ito S; Narita N
    Kansenshogaku Zasshi; 1986 Jan; 60(1):37-44. PubMed ID: 3088174
    [No Abstract]   [Full Text] [Related]  

  • 49. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients.
    Schmidt LE; Olsen AK; Stentoft K; Rasmussen A; Kirkegaard P; Dalhoff K
    Clin Pharmacol Ther; 2001 Nov; 70(5):446-54. PubMed ID: 11719731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction between FK506 and erythromycin.
    Shaeffer MS; Collier D; Sorrell MF
    Ann Pharmacother; 1994 Feb; 28(2):280-1. PubMed ID: 7513563
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of erythromycin acistrate and enterocoated erythromycin base in acute respiratory infections.
    Gordin A; Kalima S; Hulmi S; Mäkelä P; Antikainen R
    J Antimicrob Chemother; 1988 Jun; 21 Suppl D():85-92. PubMed ID: 3391879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aggravation of myasthenia gravis by erythromycin.
    May EF; Calvert PC
    Ann Neurol; 1990 Oct; 28(4):577-9. PubMed ID: 2252369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug interaction triggers weakness.
    Lilley LL; Guanci R
    Am J Nurs; 1998 Apr; 98(4):10. PubMed ID: 9556673
    [No Abstract]   [Full Text] [Related]  

  • 54. Carbamazepine toxicity precipitated by intravenous erythromycin.
    Mitsch RA
    DICP; 1989 Nov; 23(11):878-9. PubMed ID: 2596129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--second report: including cases with Pseudomonas infections].
    Sawaki M; Mikami R; Mikasa K; Kunimatsu M; Ito S; Narita N
    Kansenshogaku Zasshi; 1986 Jan; 60(1):45-50. PubMed ID: 3088175
    [No Abstract]   [Full Text] [Related]  

  • 56. Adolescent with respiratory impairments and short-lived fever.
    Loose LM; Elde E; Aune MB; Vallersnes OM
    Tidsskr Nor Laegeforen; 2015 Jun; 135(12-13):1144-7. PubMed ID: 26130549
    [No Abstract]   [Full Text] [Related]  

  • 57. Vinblastine and erythromycin: an unrecognized serious drug interaction.
    Tobe SW; Siu LL; Jamal SA; Skorecki KL; Murphy GF; Warner E
    Cancer Chemother Pharmacol; 1995; 35(3):188-90. PubMed ID: 7805175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in erythromycin pharmacokinetics induced by renal failure.
    Kanfer A; Stamatakis G; Torlotin JC; Fredj G; Kenouch S; Méry JP
    Clin Nephrol; 1987 Mar; 27(3):147-50. PubMed ID: 3494560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ototoxicity of erythromycin.
    van Marion WF; van der Meer JW; Kalff MW; Schicht SM
    Lancet; 1978 Jul; 2(8082):214-5. PubMed ID: 78420
    [No Abstract]   [Full Text] [Related]  

  • 60. Erythromycin-induced ototoxicity substantiated by rechallenge.
    Schwartz JI; Maggini GA
    Clin Pharm; 1982; 1(4):374-6. PubMed ID: 7185536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.